Long Term Clinical Outcome of Single Open Door Laminoplasty With Preservation of Unilateral Muscular Ligament Complex

August 6, 2021 updated by: Peking University Third Hospital
To collect and measure the preoperative and postoperative clinical data of the patients undergoing single open-door expansive laminoplasty with preservation of musclar ligament complex through posterior cervical approach in our hospital and summarize the long-term clinical effect and postoperative imaging changes and analyze the long-term clinical effect of this operation

Study Overview

Status

Completed

Conditions

Detailed Description

Objective: To collect and measure the preoperative and postoperative clinical data of the patients undergoing single open-door expansive laminoplasty with preservation of musclar ligament complex through posterior cervical approach in our hospital. To summarize the long-term clinical effect and postoperative imaging changes and to analyze the long-term clinical effect of this operation on cervical spondylosis. To provide scientific basis for clinical work and theoretical research in the future.

This study was a retrospective study, and the medical records of posterior cervical open-door expansive laminoplasty with musclar ligament complex preservation in the orthopedics department of our hospital from 2006 to 2017 were collected, and the patients with complete diagnosis and treatment data were selected for analysis and research.The preoperative and postoperative changes of the patients were studied by combining the patient's case and imaging examination (MR, CT, X plain film) and other diagnosis and treatment data.

Study Type

Observational

Enrollment (Actual)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100191
        • Peking University Third Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Between August 2020 and December 2021, patients receiving conventional cervical posterior open-door laminoplasty due to cervical myelopathy or ossification of the posterior longitudinal ligament of the cervical spine

Description

Inclusion Criteria:

  1. Age 18-70, gender unlimited;
  2. The patient was diagnosed with cervical spondylosis and met the indications of posterior cervical laminoplasty;
  3. Basis of serious diseases of heart, brain, lung, kidney or other important organs, preoperative ASA score I-II;
  4. Agree to participate in the study and sign the informed consent;

Exclusion Criteria:

  1. Preoperative ASA score ≥III;
  2. One-stage combined anterior and posterior surgery of cervical spine;
  3. Correction of cervical deformity;
  4. Patients with gastric emptied disorders (such as gastroesophageal reflux, chronic history of aspiration, delayed gastric emptied), complete obstruction of the digestive tract, and inability to use enteral preparations;
  5. Patients with high risk conditions, such as severe cardio-renal insufficiency, affecting the safety evaluation of the trial;
  6. People with mental disorders, alcohol dependence or drug abuse history;
  7. women in the period of lactation and pregnancy;
  8. People with allergic constitution or previous allergies to a variety of drugs;
  9. Other researchers consider it inappropriate to participate in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
ERAS group
patients received posterior cervical open-door laminoplasty under ERAS mode
Conventional group
patients received posterior cervical open-door laminoplasty under routine perioperative management mode

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NDI
Time Frame: 2 years after operation
neck disability index
2 years after operation
mJOA
Time Frame: 2 years after operation
Modified Japanese Orthopaedic Association score
2 years after operation
neck and shoulder VAS
Time Frame: 2 years after operation
neck and shoulder visual analogue score
2 years after operation
AS
Time Frame: 2 years after operation
axial syndrome
2 years after operation
C5 palsy
Time Frame: 2 years after operation
C5 palsy after operation
2 years after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2019

Primary Completion (ACTUAL)

August 31, 2020

Study Completion (ACTUAL)

June 1, 2021

Study Registration Dates

First Submitted

July 1, 2021

First Submitted That Met QC Criteria

August 6, 2021

First Posted (ACTUAL)

August 12, 2021

Study Record Updates

Last Update Posted (ACTUAL)

August 12, 2021

Last Update Submitted That Met QC Criteria

August 6, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Myelopathy

Subscribe